Our Discovery Programmes

Explore the Future of Discovery with Oxford Global

Immerse yourself in a world of scientific insight and unparalleled networking opportunities.

Join us for first-class experiences, where every event is meticulously designed to deliver exceptional value.

Our Biomarkers Programmes

07 - 08 November 2024 | Boston, MA

Discovery US 2024

Connecting experts in biology & chemistry to advance small molecule drug discovery

  • Benefit from our revamped programme for 2024, designed to provide in-depth discussion of the key technologies, modalities & platforms transforming small molecule drug discovery  
  • Discover emerging drug targets beyond the rule of five, from Induced Proximity & Molecular Glues through to siRNAs and orally-available peptides, with case studies on the chemical & biological considerations of developing these complex molecules
  • Enable your lab to operate at peak productivity. Maximize your R&D capabilities with integration of advanced robotics & automation, as well as utilizing AI to augment your drug development

Agenda at a Glance


  • Day One | Track 1: Novel Targets Beyond The Rule Of Fives
  • Day One | Track 2: Novel Models For ADME-Tox Research & Disease Modelling 
  • Day One | Track 3: Augmenting R&D With AI and Automation
  • Day Two | Track 1: Innovative Technologies For Hit Identification & Screening
  • Day Two | Track 2: Computational & Medicinal Chemistry
  • Day Two | Track 3: Genomics-Driven Drug Discovery & Bioinformatics

May 2025 | Basel, Switzerland

Discovery Europe 2025

Pushing traditional boundaries in pharmaceutical science by accelerating the discovery & development of novel therapeutics

  • The programme addresses drug discovery in new modalities such as protein degradation, and case studies on the integration of screening approaches in phenotypic and genomics-based discovery, Organ-on-a-chip and 3D modelling.
  • Examine the latest advancements and emerging trends in developing neurological treatments, including targeted approaches and novel strategies. 
  • Learn about key focus areas in drug design including AI in drug design: in chemical synthesis, target ID capabilities & lead identification/optimisation.

Agenda at a Glance


23rd Annual Drug Discovery Summit & Discovery Chemistry Europe Congress

  • Workshop 1: Organ Modelling
  • Workshop 2: Targeted Protein Degradation
  • Workshop 3: Automation or AI in Medicinal Chemistry and Drug Design

Drug Discovery Summit

  • Day One | Track 1: Identification And Validation Of Novel Targets For Next Generation
    Therapeutics
  • Day One | Track 2: Animal And Disease Modelling, Organoid And Organ On The Chip Based Discovery
  • Day One | Track 3: Discovery on Target – Screening and Genomic Strategies
  • Day Two | Track 1: Phenotypic & Target Based Discovery Approaches

Drug Design & Medicinal Chemistry Summit

  • Day One | Track 1: Computational Drug Design: AI In Chemical Synthesis, Target ID
    Capabilities, Lead Identification, Lead Optimisation, Measuring PK/PD & Prediction
  • Day Two | Track 2: Hit Finding Technologies And Advancements
  • Day Two | Track 3, Part 1: Automation And Synthesis In Organic Chemistry
  • Day Two | Track 3, Part 2: Molecular Drug Design And Med Chem: Innovations
    In Fragment & Structured Based Drug Discovery

6th Annual Neuroscience Drug Development Europe Congress

  • Day One | Track 1: Drug Discovery For Neurodegenerative Disease
  • Day Two | Track 1: Therapeutic Strategies, Enabling Technologies & Biomarker Development

4th Annual Pharmaceutical Mobile Robotics Congress & 3rd Annual SmartLabs Automation Congress

  • Day One | Track 1: Bridging The Gap Between Automation & Digitalisation through FAIR & Digital Transformation 
  • Day One | Track 2: Smart Manufacturing & Digitisation Optimisation
  • Day One | Track 3: Mobile Robotics In R&D Laboratories
  • Day Two | Track 1: Automation with AI/ML & Robotics Tools in Drug Discovery & Development 
  • Day Two | Track 2: Data-Driven Modelling & Data Analytics for Drug Discovery & Development